title: A case of ulceronecrotic Mucha-Habermann disease with pulmonary involvement.
authors.forename: I E
authors.initials: IE
authors.lastname: Aydingöz
authors.forename: N
authors.initials: N
authors.lastname: Kocaayan
authors.forename: A T
authors.initials: AT
authors.lastname: Mansur
authors.forename: S
authors.initials: S
authors.lastname: Pekcan
authors.forename: A
authors.initials: A
authors.lastname: Arman
mesh_terms: D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D017514:Pityriasis Lichenoides / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D012867:Skin / Q000473:pathology*; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D017334:Teicoplanin / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D017334:Teicoplanin; D000583:Amikacin; D008775:Methylprednisolone